1 week ago
Indian stocks in focus after orders, approvals and regulatory updates
Several Indian companies announced important business updates on August 24, 2026.
Lenskart may see an investor sell part of its stake.
Power Grid won a large project to move renewable electricity in Gujarat.
NTPC Renewable Energy won a bid to supply 500 megawatts of power.
Jubilant Pharmova received permission to make a product at a new facility in the United States.
Some drug companies received observations from the US drug regulator after inspections.
GHCL said environmental and forest clearances for its Gujarat project were upheld after challenges were dismissed.
Other companies announced new orders, factory plans, investments, leadership changes and technology developments.
Ceinsys Tech, however, said some Maharashtra water-project orders worth ₹112.42 crore were cancelled.
SoftBank Vision Fund II Lightbulb Cayman plans to sell up to a 2.6% stake in Lenskart Solutions at a floor price of ₹635 per share.
Power Grid won an ₹822.91-crore transmission project, while NTPC Renewable Energy secured 500 MW at a discovered tariff of ₹6 per kWh.
Jubilant Pharmova received USFDA approval for commercial manufacturing on a new Spokane fill-and-finish line; Caplin Point and Natco Pharma reported USFDA observations.
GHCL said the National Green Tribunal dismissed all three challenges to clearances for its Gujarat soda ash project, while Ceinsys Tech reported ₹112.42 crore of cancelled orders.
Companies including Sigachi Industries, Tega Industries, Acutaas Chemicals, BR Goyal Infrastructure and Diamond Power announced fund-raising, capital expenditure or new orders.
- Who
- The companies and institutions named in the market update, including Lenskart Solutions, Power Grid Corporation of India, NTPC Renewable Energy, Jubilant Pharmova, GHCL and Ceinsys Tech.
- What
- A range of stake-sale plans, regulatory outcomes, project awards, investment decisions, leadership changes, patents and order updates involving 20 stocks.
- Where
- The developments involve India, including Gujarat, Maharashtra, Madhya Pradesh, Hyderabad, West Bengal and other locations, as well as facilities in Spokane, Washington, United States, and a proposed entity in Germany.
- When
- The updates were published on August 24, 2026; the reported USFDA inspections took place between August 13 and 21, 2026, and August 17 and 21, 2026.
- Why
- The companies reported these developments because they could affect ownership, manufacturing, project execution, regulatory status, capacity, orders or future operations.
Key facts
- Lenskart stake sale
- SoftBank Vision Fund II Lightbulb Cayman plans to sell up to a 2.6% stake in Lenskart Solutions at ₹635 per share or more.
- Power Grid project
- Power Grid Corporation of India secured an ₹822.91-crore-per-annum work order for a 6,500 MW renewable-energy transmission system in Gujarat.
- NTPC Renewable Energy bid
- NTPC Renewable Energy secured 500 MW under an assured peak-supply tender at a discovered tariff of ₹6 per kWh.
- Jubilant approval
- The USFDA approved commercial batch manufacturing of the first product on Line 3 at Jubilant HollisterStier’s Spokane facility.
- USFDA observations
- Caplin Steriles received 10 observations, while Natco Pharma’s Visakhapatnam unit and Choksi Laboratories’ Indore laboratory each received four observations.
- GHCL clearances
- The National Green Tribunal’s Western Zone Bench dismissed all three appeals challenging GHCL’s environmental and forest clearances.
- Ceinsys Tech cancellation
- Ceinsys Tech reported a ₹112.42-crore reduction in pending executable orders after 617 Maharashtra schemes were cancelled.
- Sigachi warrants
- Sigachi Industries approved up to 11 crore convertible warrants at ₹26.40 each, including 7.5 crore warrants for promoter Amit Raj Sinha.
Sources
Related news
Stocks in News: IPO Debuts, Stake Sales, and Corporate Updates
Indian stocks surge on realty deals, pharma approvals, rail contracts
SoftBank Vision Fund May Sell 2.6% Lenskart Stake
Indian stocks in focus ahead of August 31 trading
Aurobindo Pharma’s US Unit Reports Four FDA Observations
Indian Stocks Gain Attention on Orders, Expansions and Deals
BIT Mesra Celebrates 72nd Foundation Day
Indian Companies Report Mixed Financials Amid Corporate Actions
